rs1127745
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_003500.4(ACOX2):āc.1302T>Cā(p.Cys434=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.125 in 1,613,910 control chromosomes in the GnomAD database, including 23,975 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.25 ( 8940 hom., cov: 33)
Exomes š: 0.11 ( 15035 hom. )
Consequence
ACOX2
NM_003500.4 synonymous
NM_003500.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.927
Genes affected
ACOX2 (HGNC:120): (acyl-CoA oxidase 2) The product of this gene belongs to the acyl-CoA oxidase family. It encodes the branched-chain acyl-CoA oxidase which is involved in the degradation of long branched fatty acids and bile acid intermediates in peroxisomes. Deficiency of this enzyme results in the accumulation of branched fatty acids and bile acid intermediates, and may lead to Zellweger syndrome, severe cognitive disability, and death in children. [provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 3-58526510-A-G is Benign according to our data. Variant chr3-58526510-A-G is described in ClinVar as [Benign]. Clinvar id is 1600142.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.927 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.617 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ACOX2 | NM_003500.4 | c.1302T>C | p.Cys434= | synonymous_variant | 10/15 | ENST00000302819.10 | |
ACOX2 | XM_047449042.1 | c.1500T>C | p.Cys500= | synonymous_variant | 10/15 | ||
ACOX2 | XM_005265505.2 | c.1302T>C | p.Cys434= | synonymous_variant | 10/15 | ||
ACOX2 | XM_006713340.4 | c.1008T>C | p.Cys336= | synonymous_variant | 9/14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ACOX2 | ENST00000302819.10 | c.1302T>C | p.Cys434= | synonymous_variant | 10/15 | 1 | NM_003500.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.250 AC: 38079AN: 152050Hom.: 8893 Cov.: 33
GnomAD3 genomes
AF:
AC:
38079
AN:
152050
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.148 AC: 37104AN: 250698Hom.: 5058 AF XY: 0.138 AC XY: 18715AN XY: 135484
GnomAD3 exomes
AF:
AC:
37104
AN:
250698
Hom.:
AF XY:
AC XY:
18715
AN XY:
135484
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.112 AC: 163702AN: 1461740Hom.: 15035 Cov.: 32 AF XY: 0.111 AC XY: 80608AN XY: 727158
GnomAD4 exome
AF:
AC:
163702
AN:
1461740
Hom.:
Cov.:
32
AF XY:
AC XY:
80608
AN XY:
727158
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.251 AC: 38187AN: 152170Hom.: 8940 Cov.: 33 AF XY: 0.246 AC XY: 18317AN XY: 74392
GnomAD4 genome
AF:
AC:
38187
AN:
152170
Hom.:
Cov.:
33
AF XY:
AC XY:
18317
AN XY:
74392
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
632
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at